18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia
Clinical trial NCT06880328 · COMPLETED
Trial details
- NCT number
- NCT06880328
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-07
- Primary completion
- 2019-09-04
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.